Categories: GrowthMedtech
Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm.
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 24.08.2023 |
FDA fast-tracks aneurysm stabilization system from Nectero Medical | The EAST system. [Image courtesy of Nectero Medical]Nectero Medical announced today that the FDA granted fast track designation to its endovascular aneurysm stabilization treatment (EAST) system.
Tempe, Arizona–based Nectero designed its EA... |
| 08.08.2023 | Astute Imaging and Nectero Medical to Collaborate in Groundbreaking Aortic Aneurysm Trial | Astute Imaging’s AI-driven, image-based RWE platform is a major, disruptive technology for medical device companies, enabling near real-time visibility of implanted device performance
KIRKLAND, Wash. (PRWEB) August 08, 2023
Astute Imaging, ... |
| - | Nectero Medical | “Nectero Medical – Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).” |
Reviews 0
